127 related articles for article (PubMed ID: 36123899)
1. Hub genes for early diagnosis and therapy of adamantinomatous craniopharyngioma.
Zou YF; Zhang SY; Li LW; Jing K; Xia L; Sun CX; Wu B
Medicine (Baltimore); 2022 Sep; 101(37):e30278. PubMed ID: 36123899
[TBL] [Abstract][Full Text] [Related]
2. Identification and Functional Enrichment Analysis of Potential Diagnostic and Therapeutic Targets in Adamantinomatous Craniopharyngioma.
Zou YF; Meng LB; Wang QQ; He ZK; Hu CH; Shan MJ; Wang DY; Yu X
J Comput Biol; 2020 Jan; 27(1):55-68. PubMed ID: 31424286
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles reveal key genes for early diagnosis and treatment of adamantinomatous craniopharyngioma.
Yang J; Hou Z; Wang C; Wang H; Zhang H
Cancer Gene Ther; 2018 Oct; 25(9-10):227-239. PubMed ID: 29681617
[TBL] [Abstract][Full Text] [Related]
4. Integrative analyses identify HIF-1α as a potential protective role with immune cell infiltration in adamantinomatous craniopharyngioma.
Gao Q; Luo J; Pan J; Zhang L; Song D; Zhang M; Xu D; Guo F
Front Immunol; 2022; 13():949509. PubMed ID: 36091021
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targets.
Prince E; Whelan R; Donson A; Staulcup S; Hengartner A; Vijmasi T; Agwu C; Lillehei KO; Foreman NK; Johnston JM; Massimi L; Anderson RCE; Souweidane MM; Naftel RP; Limbrick DD; Grant G; Niazi TN; Dudley R; Kilburn L; Jackson EM; Jallo GI; Ginn K; Smith A; Chern JJ; Lee A; Drapeau A; Krieger MD; Handler MH; Hankinson TC;
Acta Neuropathol Commun; 2020 May; 8(1):68. PubMed ID: 32404202
[TBL] [Abstract][Full Text] [Related]
6. Integrative Analysis of Biomarkers and Mechanisms in Adamantinomatous Craniopharyngioma.
Lin D; Zhao W; Yang J; Wang H; Zhang H
Front Genet; 2022; 13():830793. PubMed ID: 35432485
[TBL] [Abstract][Full Text] [Related]
7. Adamantinomatous craniopharyngioma: moving toward targeted therapies.
Hengartner AC; Prince E; Vijmasi T; Hankinson TC
Neurosurg Focus; 2020 Jan; 48(1):E7. PubMed ID: 31896087
[TBL] [Abstract][Full Text] [Related]
8. Exploration of the shared pathways and common biomarker in adamantinomatous craniopharyngioma and type 2 diabetes using integrated bioinformatics analysis.
Han Y; Wang Y; Li S; Sato K; Yamagishi S
PLoS One; 2024; 19(6):e0304404. PubMed ID: 38848397
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA sequencing highlights intratumor heterogeneity and intercellular network featured in adamantinomatous craniopharyngioma.
Jiang Y; Yang J; Liang R; Zan X; Fan R; Shan B; Liu H; Li L; Wang Y; Wu M; Qi X; Chen H; Ren Q; Liu Z; Wang Y; Zhang J; Zhou P; Li Q; Tian M; Yang J; Wang C; Li X; Jiang S; Zhou L; Zhang G; Chen Y; Xu J
Sci Adv; 2023 Apr; 9(15):eadc8933. PubMed ID: 37043580
[TBL] [Abstract][Full Text] [Related]
10. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.
Apps JR; Carreno G; Gonzalez-Meljem JM; Haston S; Guiho R; Cooper JE; Manshaei S; Jani N; Hölsken A; Pettorini B; Beynon RJ; Simpson DM; Fraser HC; Hong Y; Hallang S; Stone TJ; Virasami A; Donson AM; Jones D; Aquilina K; Spoudeas H; Joshi AR; Grundy R; Storer LCD; Korbonits M; Hilton DA; Tossell K; Thavaraj S; Ungless MA; Gil J; Buslei R; Hankinson T; Hargrave D; Goding C; Andoniadou CL; Brogan P; Jacques TS; Williams HJ; Martinez-Barbera JP
Acta Neuropathol; 2018 May; 135(5):757-777. PubMed ID: 29541918
[TBL] [Abstract][Full Text] [Related]
11. Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing.
He J; Zeng Z; Wang Y; Deng J; Tang X; Liu F; Huang J; Chen H; Liang R; Zan X; Liu Z; Tong A; Guo G; Xu J; Zhu X; Zhou L; Peng Y
Mol Cancer; 2021 Dec; 20(1):168. PubMed ID: 34922552
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
13. Craniopharyngioma: a roadmap for scientific translation.
Gupta S; Bi WL; Giantini Larsen A; Al-Abdulmohsen S; Abedalthagafi M; Dunn IF
Neurosurg Focus; 2018 Jun; 44(6):E12. PubMed ID: 29852761
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis.
Prince EW; Apps JR; Jeang J; Chee K; Medlin S; Jackson EM; Dudley R; Limbrick D; Naftel R; Johnston J; Feldstein N; Prolo LM; Ginn K; Niazi T; Smith A; Kilburn L; Chern J; Leonard J; Lam S; Hersh DS; Gonzalez-Meljem JM; Amani V; Donson AM; Mitra SS; Bandopadhayay P; Martinez-Barbera JP; Hankinson TC
Neuro Oncol; 2024 Jun; 26(6):1109-1123. PubMed ID: 38334125
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the pathogenesis of Sjögren's syndrome via DNA methylation and transcriptome analyses.
Du Y; Li J; Wu J; Zeng F; He C
Clin Rheumatol; 2022 Sep; 41(9):2765-2777. PubMed ID: 35562622
[TBL] [Abstract][Full Text] [Related]
16. Potential evolution of neurosurgical treatment paradigms for craniopharyngioma based on genomic and transcriptomic characteristics.
Robinson LC; Santagata S; Hankinson TC
Neurosurg Focus; 2016 Dec; 41(6):E3. PubMed ID: 27903126
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis and validation of the critical genes associated with adamantinomatous craniopharyngioma.
Fang C; Zhou L; Huang H; Xu HT; Hong T; Zheng SY
Front Oncol; 2022; 12():1007236. PubMed ID: 36387067
[TBL] [Abstract][Full Text] [Related]
18. Weighted Gene Co-Expression Network Analysis Identifies Hub Genes Associated with Occurrence and Prognosis of Oral Squamous Cell Carcinoma.
Ge Y; Li W; Ni Q; He Y; Chu J; Wei P
Med Sci Monit; 2019 Sep; 25():7272-7288. PubMed ID: 31562292
[TBL] [Abstract][Full Text] [Related]
19. Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
Stache C; Bils C; Fahlbusch R; Flitsch J; Buchfelder M; Stefanits H; Czech T; Gaipl U; Frey B; Buslei R; Hölsken A
Neurosurg Focus; 2016 Dec; 41(6):E14. PubMed ID: 27903123
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma.
Andoniadou CL; Gaston-Massuet C; Reddy R; Schneider RP; Blasco MA; Le Tissier P; Jacques TS; Pevny LH; Dattani MT; Martinez-Barbera JP
Acta Neuropathol; 2012 Aug; 124(2):259-71. PubMed ID: 22349813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
